These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3266233)

  • 1. Neurotoxic damage to the nigrostriatal system in rats following intranigral administration of MPDP+ and MPP+.
    Sun CJ; Johannessen JN; Gessner W; Namura I; Singhaniyom W; Brossi A; Chiueh CC
    J Neural Transm; 1988; 74(2):75-86. PubMed ID: 3266233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion.
    Sirinathsinghji DJ; Heavens RP; Richards SJ; Beresford IJ; Hall MD
    Neuroscience; 1988 Oct; 27(1):117-28. PubMed ID: 3264391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+).
    Lange KW
    J Toxicol Clin Exp; 1989; 9(1):21-5. PubMed ID: 2787400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
    Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
    Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM; Arora PK; Iacofano LA; Harik SI
    Eur J Pharmacol; 1986 May; 124(1-2):171-4. PubMed ID: 3487462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC
    Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.
    Lange KW
    Eur J Pharmacol; 1990 Jan; 175(1):57-61. PubMed ID: 2323346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA; Kindt MV; Heikkila RE
    J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+).
    Neafsey EJ; Drucker G; Raikoff K; Collins MA
    Neurosci Lett; 1989 Nov; 105(3):344-9. PubMed ID: 2594220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G; Nwanze E; Luthman J; Sundström E
    Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation.
    Altar CA; Heikkila RE; Manzino L; Marien MR
    Eur J Pharmacol; 1986 Nov; 131(2-3):199-209. PubMed ID: 3493157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
    Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with age.
    Irwin I; Ricaurte GA; DeLanney LE; Langston JW
    Neurosci Lett; 1988 Apr; 87(1-2):51-6. PubMed ID: 3260017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice.
    Sundström E; Goldstein M; Jonsson G
    Eur J Pharmacol; 1986 Nov; 131(2-3):289-92. PubMed ID: 3493159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prenatal treatment with MPTP or MPP+ on the development of dopamine-mediated behaviors in rats.
    Weissman EM; Norman AB; Calderon SF; Zubrycki EM; el-Etri MM; Shipley MT; Sanberg PR
    Pharmacol Biochem Behav; 1989 Nov; 34(3):545-51. PubMed ID: 2623012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.